A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso - No Study Results Posted

A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso (MSP3LSP)

This study is currently recruiting participants.

Study NCT00452088 Information provided by African Malaria Network Trust

First Received: March 23, 2007 Last Updated: May 6, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	May 2008
Estimated Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)

No publications provided by African Malaria Network Trust

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma EC, Konaté AT, Kaboré Y, Traoré A, Roma C, Soulama I, Luty AJ, Cousens S, Nébié I. Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children. PLoS One. 2009 Oct 26;4(10):e7549.